| The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ... leukemia 36 (7), 1703-1719, 2022 | 1957 | 2022 |
| AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance T O'Hare, WC Shakespeare, X Zhu, CA Eide, VM Rivera, F Wang, ... Cancer cell 16 (5), 401-412, 2009 | 1434 | 2009 |
| Functional genomic landscape of acute myeloid leukaemia JW Tyner, CE Tognon, D Bottomly, B Wilmot, SE Kurtz, SL Savage, ... Nature 562 (7728), 526-531, 2018 | 1081 | 2018 |
| CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability BJ Lannutti, SA Meadows, SEM Herman, A Kashishian, B Steiner, ... Blood, The Journal of the American Society of Hematology 117 (2), 591-594, 2011 | 875 | 2011 |
| Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease EY Kim, JT Battaile, AC Patel, Y You, E Agapov, MH Grayson, LA Benoit, ... Nature medicine 14 (6), 633-640, 2008 | 624 | 2008 |
| Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML JE Maxson, J Gotlib, DA Pollyea, AG Fleischman, A Agarwal, CA Eide, ... New England Journal of Medicine 368 (19), 1781-1790, 2013 | 614 | 2013 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 471 | 2019 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 413 | 2021 |
| Activating alleles of JAK3 in acute megakaryoblastic leukemia DK Walters, T Mercher, TL Gu, T O'Hare, JW Tyner, M Loriaux, VL Goss, ... Cancer cell 10 (1), 65-75, 2006 | 366 | 2006 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 342 | 2020 |
| CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection JW Tyner, O Uchida, N Kajiwara, EY Kim, AC Patel, MP O'Sullivan, ... Nature medicine 11 (11), 1180-1187, 2005 | 332 | 2005 |
| Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals JW Tyner, EY Kim, K Ide, MR Pelletier, WT Roswit, JD Morton, JT Battaile, ... The Journal of clinical investigation 116 (2), 309-321, 2006 | 306 | 2006 |
| CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia A Pardanani, TL Lasho, RR Laborde, M Elliott, CA Hanson, RA Knudson, ... Leukemia 27 (9), 1870-1873, 2013 | 279 | 2013 |
| CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms JW Tyner, TG Bumm, J Deininger, L Wood, KJ Aichberger, MM Loriaux, ... Blood, The Journal of the American Society of Hematology 115 (25), 5232-5240, 2010 | 271 | 2010 |
| The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells T Nechiporuk, SE Kurtz, O Nikolova, T Liu, CL Jones, A D'Alessandro, ... Cancer discovery 9 (7), 910-925, 2019 | 268 | 2019 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 232 | 2021 |
| Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia A Carey, DK Edwards, CA Eide, L Newell, E Traer, BC Medeiros, ... Cell reports 18 (13), 3204-3218, 2017 | 230 | 2017 |
| Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia V Frismantas, MP Dobay, A Rinaldi, J Tchinda, SH Dunn, J Kunz, ... Blood, The Journal of the American Society of Hematology 129 (11), e26-e37, 2017 | 221 | 2017 |
| The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment J Gotlib, JE Maxson, TI George, JW Tyner Blood, The Journal of the American Society of Hematology 122 (10), 1707-1711, 2013 | 201 | 2013 |
| Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma YY Jiang, DC Lin, A Mayakonda, M Hazawa, LW Ding, WW Chien, L Xu, ... Gut 66 (8), 1358-1368, 2017 | 195 | 2017 |
